Alexion makes $930M acquisition in bid to bolster blockbuster drug
October 16, 2019 at 11:43 AM EDT
Alexion says it will acquire clinical-stage startup Achillion Pharmaceuticals Inc. for $930 million upfront.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|